- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Sun Pharmaceutical Industries Limited has released its Sustainability Report for FY2023-24, highlighting the company's commitment to Environmental, Social, and Governance (ESG) performance.
The report reveals a significant 18% reduction in absolute carbon emissions (Scope 1 and 2) and a 21% decrease in water consumption compared to the baseline of 2020. Renewable energy sources now make up 38% of the company’s total energy mix. In its mission to enhance workplace diversity, Sun Pharma aims to achieve a 30% representation of women in its workforce by 2040. The company's commitment to community development is underscored by a CSR spend of ₹1,164 million, impacting over one million lives through initiatives in healthcare, education, and environmental conservation.
Looking ahead, Sun Pharma targets a 35% reduction in carbon emissions and strives to become water positive by 2030. The company is actively improving its sustainability practices while managing risks associated with climate change, maintaining a positive outlook for future growth.
All announcements from Sun Pharmaceutical Industries Limited